N | TAVI with BAV N = 339 | TAVI without BAV N = 355 | P-value | |
---|---|---|---|---|
Patient characteristics | ||||
Age (years) | 694 | 82 (79–86) | 81 (78–86) | 0.057 |
Female (%) | 694 | 49.9 | 45.4 | 0.254 |
Height (cm) | 694 | 166 (160–172) | 168 (160–175) | 0.052 |
Weight (kg) | 694 | 72 (63–82) | 75 (63–87) | 0.027 |
Body surface area (cm2)a | 694 | 1.81 (1.68–1.94) | 1.84 (1.68–2.01) | 0.032 |
BMI (kg/m2) | 692 | 26 (23–29) | 26 (24–30) | 0.207 |
Hypertension (%) | 678 | 85.2 | 88.4 | 0.255 |
Diabetes (%) | 676 | 31.0 | 32.9 | 0.621 |
Stroke, TIA (%) | 678 | 13.5 | 16 | 0.387 |
Peripheral artery disease (%) | 679 | 43.4 | 23.9 | < 0.001 |
Pulmonary hypertension (%) | 527 | 33.0 | 38.6 | 0.202 |
Creatinine > 2 mg/dL (%) | 694 | 5.9 | 6.2 | 0.875 |
Dialysis (%) | 361 | 6.4 | 2.7 | 0.108 |
Coronary artery disease (%) | 694 | 61.9 | 64.8 | 0.478 |
Prior myocardial infarction (%) | 557 | 29.8 | 24.4 | 0.182 |
Prior CV intervention (%) | 694 | 36.3 | 44.8 | 0.025 |
Prior pacemaker / ICD implant (%) | 501 | 17.6 | 12.7 | 0.152 |
EuroSCORE II | 588 | 4 (2–8) | 5 (3–10) | 0.005 |
STS Risk Score | 616 | 5.3 (3.2–10.0) | 4.6 (3.0–8.0) | 0.002 |
Disease characteristics | ||||
Echo AV peak PG (mmHg) | 533 | 70 (57–82) | 69 (55–81) | 0.275 |
Echo AV mean PG (mmHg) | 649 | 43 (35–54) | 41 (33–50) | 0.111 |
Echo Vmax (m/s) | 435 | 4.0 (3.7–4.4) | 4.1 (3.6–4.5) | 0.965 |
Echo ejection fraction (%) | 653 | 55 (47–60) | 55 (45–60) | 0.324 |
Effective orifice area | 534 | 0.70 (0.57–0.80) | 0.70 (0.60–0.80) | 0.043 |
Indexed effective orifice areab | 533 | 0.38 (0.31–0.46) | 0.39 (0.32–0.46) | 0.348 |
NYHA Class III or IV | 685 | 79.8 | 75.9 | 0.232 |
CCS grading of angina pectoris Class III or IV | 645 | 16.8 | 17.0 | 1.000 |
Dizziness or syncope | 694 | 30.1 | 30.1 | 1.000 |